The main objective of this study was to collect information on WILLFACT/WILFACTIN in real life clinical use and to identify the therapeutic practices in an international environment.
To address the study objectives, the following study endpoints were defined:
Primary Endpoints:
· Documentation of product consumption data and analysis of
posology, frequency, and prescriptions in relation to the severity of
bleeding, type of surgery and other clinical situations
· Product satisfaction measured via a 4-points scale questionnaire
based on physician and patient assessments